This act establishes a mandatory, uniform VA National Formulary, grants the VA new authority to negotiate drug discounts, creates a Pharmacy and Therapeutics Committee, and sets up a tiered copayment system to promote cost-effective medication use for veterans.
Mariannette Miller-Meeks
Representative
IA-1
The VA National Formulary Act of 2025 mandates the creation of a single, uniform national formulary for all VA medical facilities, managed by a new expert committee. This law standardizes drug access, streamlines the process for requesting non-formulary medications, and grants the VA new authority to negotiate supplemental drug discounts. Finally, it establishes a tiered copayment system to incentivize the use of cost-effective medications.
The VA National Formulary Act of 2025 is designed to end the 'zip code lottery' for veterans' medications. Currently, what a veteran can get at a VA in Florida might differ from what’s available in Oregon because local regions (VISNs) often manage their own lists. This bill mandates a single, uniform National Formulary—a master list of every drug and supply available at every VA facility nationwide. By centralizing this, the bill ensures that if you move or travel, your prescriptions stay consistent across the entire system. It also cracks down on pharmaceutical influence by requiring the doctors and pharmacists who pick these drugs to have zero financial ties to the industry, backed by annual public disclosures.
We all know the frustration of needing a specific medication that isn't on the 'approved' list. Section 2 of the bill fixes the waiting game by requiring a standardized electronic request system integrated directly into your health records. If your doctor needs to prescribe something off-formulary, the VA must give an initial 'yes' or 'no' within 96 hours. If they say no, you have the right to an appeal that must be settled within seven days. This is a massive shift for veterans dealing with chronic pain or mental health issues who can’t afford to wait weeks for a bureaucrat to sign off on a life-changing pill.
To keep costs down, the bill introduces a tiered copayment system. Think of it like your employer’s health plan: generic and standard formulary drugs will have lower copays, while brand-name or non-formulary drugs will cost more out-of-pocket (Section 3). To balance this out, the VA is getting new teeth to negotiate 'supplemental discounts' with drug makers. They can essentially tell a manufacturer, 'We’ll put your drug on our preferred list if you give our veterans a better price.' While this helps the VA’s bottom line, the bill also allows for 'value-based' contracts—meaning the VA might only pay full price if the drug actually works for the veterans taking it.
Because a national list could feel like it's being run by people in D.C. who don't see patients, the bill creates a temporary Veterans Formulary Advisory Committee (Section 4). For the next two years, this group of ten people—including front-line VA doctors and pharmacists who aren't part of the national decision-making board—will provide a reality check on how these drug choices affect actual care. While their role is advisory, they serve as a 'boots on the ground' perspective to ensure that cost-saving measures don't accidentally pull the rug out from under veterans with complex medical needs.